Coronavirus Policy Watch

  • Your Selections:

Refine Results

date

Update on COVID-19 Funding for Hospitals and Other Providers

This blog is an overview of the outstanding questions related to the $100 billion for hospitals and other providers in the CARES Act and whether there will be meaningful protections for the uninsured and people with private coverage who could face surprise bills.

Free Coronavirus Testing for Privately Insured Patients?

While privately insured people are eligible to have the cost of coronavirus testing covered 100% by their health plan, that doesn’t mean that insured patients won’t be asked to pay up front for the cost of testing or that they can easily be reimbursed.

What Testing Capacity Do We Need?

This post looks at potential benchmarks for estimating the number of coronavirus tests needed in the United States and compares them to current national, and state level, testing levels.

COVID-19 Models: Can They Tell Us What We Want to Know?

This blog gives a primer on epidemiological models for Covid-19 (coronavirus). It describes the uses and the types of models used, then lists a number of examples of different types of models and some key findings. The post also describes the limitations and assumptions related to these models, and how to use the information they provide more effectively.

Medicare Beneficiaries Without Supplemental Coverage Are at Risk for Out-of-Pocket Costs Relating to COVID-19 Treatment

Most Medicare Advantage enrollees are in plans that have waived cost sharing for COVID-19 treatment, and many other beneficiaries in traditional Medicare have their cost sharing covered by supplemental insurance. This blog post discusses the 6 million Medicare beneficiaries without supplemental coverage who would face out-of-pocket costs if they require treatment for COVID-19.

Managing HIV During COVID-19: Working to End One Epidemic While Confronting Another

As the COVID-19 outbreak continues to grow in the United States, it threatens efforts to address existing health challenges, including the HIV/AIDS epidemic. This blog piece explores whether efforts to “end the HIV epidemic” can be sustained while confronting COVID-19, particularly as the very systems and workforce needed to address HIV are being stretched thin to confront the new crisis.